Matthew Ros
CIK 1673802 · Chief Operating Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$205.0K
Companies
4
Total Filings
44
Lifetime Open-Market Net
-$3.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Director | — | $33.10 | — | $0 | 19 | 2026-06-11 |
| VSTM | Chief Operating Officer | 50,000 | $4.10 | $205.0K | $0 | 1 | 2025-04-03 |
| Epizyme, Inc. (EPZM) Delisted | See Remarks | 111,313 | $1.47 | $163.6K | -$3.75M | 17 | 2021-08-18 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 7 | 2020-10-02 |
Recent Filings · Page 5 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-06 | Epizyme, Inc. (EPZM) Delisted | Mixed | — | -$509.4K | EDGAR |
| 2017-03-02 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +1,708 | $10.6K | EDGAR |
| 2017-02-09 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-17 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–44 of 44
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.